Bristol Myers Squibb Co. (BMY): Is This Company Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Eli Lilly & Co (LLY)
Market is closed
News
- First
- << Previous
- 631 - 640
- Next >>
AstraZeneca plc (ADR) (AZN): Hedge Funds are Bearish...What to Do?
Is AstraZeneca plc (ADR) (NYSE:AZN) worth your attention right now? The smart money is becoming less confident. The number of long hedge fund bets fell by 2 lately.
Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK): Three Ways Big Pharma Is Seizing This Rare Opportunity
Making money in business typically happens in one of two ways. You either sell a relatively low-cost product to a large number of customers.
Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY): This Pharma's Dividend Is Safe for Now
Recently, with the loss of patents causing generic competition, the main attraction to pharmaceutical companies has been their dividend.
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY), Regeneron Pharmaceuticals Inc (REGN): Is Johnson & Johnson (JNJ) a Cash King?
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting cash back in your pocket...
Eli Lilly & Co. (NYSE:LLY): Insiders Are Dumping, Should You?
To most shareholders, hedge funds are seen as slow, outdated investment vehicles of the past.
Pfizer Inc. (PFE), Johnson & Johnson (JNJ): Is Obamacare a Disaster Waiting to Happen for Big Pharma?
Big pharma loves Obamacare, right? After all, the main lobbying group for big pharma, the Pharmaceutical Researchers and Manufacturers of America, or PhRMA, spent $150 million on an advertising campaign...
SUPERVALU INC. (SVU), AstraZeneca plc (ADR) (AZN): Whoa! What Just Happened to My Stock?
The EU's decision to seize the bank accounts of ordinary Cypriot depositors was front and center again as concerns that the financial sector could come under tremendous pressure should the crisis ripple...
Orphan Drug Is Headed Back to Its Parent: NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is bringing its kids home.
- First
- << Previous
- 631 - 640
- Next >>
Billionaire Hedge Funds
